J.P. Morgan Reaffirms Their Sell Rating on BioNTech SE (BNTX) | Markets Insider

Retrieved on: 2024-08-07 15:41:10

Tags for this article:

BioNTech

Medical research

Pfizer-BioNTech COVID-19 vaccine

Alkermes

Click the tags to see associated articles and topics

J.P. Morgan Reaffirms Their Sell Rating on BioNTech SE (BNTX) | Markets Insider. View article details on hiswai:

Summary

The article discusses Jessica Fye's investment rating on BioNTech, with mentions of the company's financial standings and other stocks she covers, including Alkermes. This relates to the key concept of 'Covid 19' as BioNTech, partnered with Pfizer, developed a prominent COVID-19 vaccine. Tags reflect the companies and products discussed.

Article found on: markets.businessinsider.com

View Original Article